Gene Symbol | Gene ID | Gene Info |
---|---|---|
Cux1
|
ENSMUSG00000029705.11 | cut-like homeobox 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr5_136555873_136556039 | Cux1 | 9476 | 0.207918 | -0.74 | 1.1e-10 | Click! |
chr5_136619734_136619985 | Cux1 | 52369 | 0.119767 | -0.67 | 1.7e-08 | Click! |
chr5_136608928_136609080 | Cux1 | 41514 | 0.145552 | -0.64 | 1.7e-07 | Click! |
chr5_136568838_136569109 | Cux1 | 1483 | 0.448327 | -0.62 | 5.0e-07 | Click! |
chr5_136565047_136565198 | Cux1 | 310 | 0.911689 | -0.61 | 7.5e-07 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr3_88230737_88231417 | 20.07 |
Gm3764 |
predicted gene 3764 |
2294 |
0.13 |
chr12_27064915_27065316 | 18.29 |
Gm9866 |
predicted gene 9866 |
49880 |
0.18 |
chr6_13836056_13836566 | 13.51 |
Gpr85 |
G protein-coupled receptor 85 |
930 |
0.6 |
chr17_87676993_87677384 | 13.18 |
Msh2 |
mutS homolog 2 |
4579 |
0.24 |
chr13_39523613_39524251 | 13.04 |
Gm47351 |
predicted gene, 47351 |
9171 |
0.2 |
chr9_71976147_71976576 | 12.05 |
Gm37663 |
predicted gene, 37663 |
14910 |
0.1 |
chr11_19554563_19554970 | 11.92 |
Gm12027 |
predicted gene 12027 |
73295 |
0.11 |
chr5_74999059_74999549 | 11.50 |
Gm42577 |
predicted gene 42577 |
10238 |
0.14 |
chr6_71925272_71925574 | 11.16 |
Polr1a |
polymerase (RNA) I polypeptide A |
671 |
0.56 |
chr9_39557637_39557818 | 10.82 |
Olfr958 |
olfactory receptor 958 |
3673 |
0.12 |
chr3_83098548_83099077 | 10.66 |
Dchs2 |
dachsous cadherin related 2 |
29136 |
0.13 |
chr1_173366486_173366732 | 10.52 |
Cadm3 |
cell adhesion molecule 3 |
1024 |
0.49 |
chr3_66935635_66935786 | 10.46 |
Gm43516 |
predicted gene 43516 |
17831 |
0.16 |
chr8_10701350_10701501 | 10.36 |
Gm44785 |
predicted gene 44785 |
11259 |
0.13 |
chr5_78622542_78622942 | 10.33 |
Gm43232 |
predicted gene 43232 |
82214 |
0.11 |
chr4_39344371_39344735 | 10.13 |
Gm23607 |
predicted gene, 23607 |
49090 |
0.15 |
chr14_68083721_68083923 | 10.04 |
Nefl |
neurofilament, light polypeptide |
41 |
0.97 |
chr3_66326110_66326323 | 10.02 |
Veph1 |
ventricular zone expressed PH domain-containing 1 |
29379 |
0.18 |
chr15_103519019_103519226 | 9.80 |
Pde1b |
phosphodiesterase 1B, Ca2+-calmodulin dependent |
4202 |
0.16 |
chr6_127701185_127701975 | 9.76 |
Gm43634 |
predicted gene 43634 |
57140 |
0.08 |
chr15_25754647_25755340 | 9.73 |
Myo10 |
myosin X |
2014 |
0.38 |
chr2_180758984_180759174 | 9.49 |
Gm14343 |
predicted gene 14343 |
16324 |
0.1 |
chr3_127387010_127387518 | 9.45 |
Gm42969 |
predicted gene 42969 |
6442 |
0.16 |
chr16_63806861_63807216 | 9.30 |
Epha3 |
Eph receptor A3 |
56375 |
0.15 |
chr5_140095235_140095604 | 9.28 |
Gm16121 |
predicted gene 16121 |
5780 |
0.17 |
chr2_13175920_13176272 | 9.26 |
Gm37780 |
predicted gene, 37780 |
12473 |
0.2 |
chr19_41746384_41746957 | 9.26 |
Slit1 |
slit guidance ligand 1 |
3005 |
0.27 |
chr16_64069102_64069325 | 9.26 |
Gm49627 |
predicted gene, 49627 |
114083 |
0.07 |
chr4_124881310_124881874 | 9.24 |
Epha10 |
Eph receptor A10 |
693 |
0.52 |
chr6_110645082_110646220 | 9.19 |
Grm7 |
glutamate receptor, metabotropic 7 |
69 |
0.76 |
chr10_62099786_62100241 | 9.17 |
Fam241b |
family with sequence similarity 241, member B |
10483 |
0.16 |
chr16_77405449_77405762 | 9.14 |
Gm21816 |
predicted gene, 21816 |
4758 |
0.13 |
chr5_133718570_133718754 | 9.12 |
Gm36667 |
predicted gene, 36667 |
120256 |
0.06 |
chr3_5221520_5221703 | 9.05 |
Zfhx4 |
zinc finger homeodomain 4 |
106 |
0.92 |
chr3_88239048_88239748 | 8.90 |
Gm3764 |
predicted gene 3764 |
10615 |
0.07 |
chr2_137705540_137705727 | 8.76 |
Gm14064 |
predicted gene 14064 |
42198 |
0.22 |
chr5_150906447_150906658 | 8.70 |
Gm43298 |
predicted gene 43298 |
23910 |
0.17 |
chr14_64592815_64593240 | 8.65 |
Mir3078 |
microRNA 3078 |
1842 |
0.26 |
chr10_37272043_37272224 | 8.56 |
4930543K20Rik |
RIKEN cDNA 4930543K20 gene |
8385 |
0.26 |
chr1_33907000_33907336 | 8.55 |
Bend6 |
BEN domain containing 6 |
600 |
0.53 |
chr13_84448589_84449243 | 8.43 |
Gm26927 |
predicted gene, 26927 |
108803 |
0.07 |
chr2_52558802_52558953 | 8.30 |
Cacnb4 |
calcium channel, voltage-dependent, beta 4 subunit |
310 |
0.9 |
chr4_151696178_151696329 | 8.30 |
Camta1 |
calmodulin binding transcription activator 1 |
165397 |
0.03 |
chr10_29148261_29148463 | 8.30 |
Soga3 |
SOGA family member 3 |
565 |
0.72 |
chr6_111449035_111449353 | 8.29 |
Grm7 |
glutamate receptor, metabotropic 7 |
46521 |
0.2 |
chr5_75012891_75013099 | 8.23 |
Gm42576 |
predicted gene 42576 |
10086 |
0.13 |
chr4_102759098_102759913 | 8.22 |
Sgip1 |
SH3-domain GRB2-like (endophilin) interacting protein 1 |
283 |
0.93 |
chr13_83732174_83732508 | 8.20 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
225 |
0.89 |
chr4_6912973_6913331 | 8.17 |
Tox |
thymocyte selection-associated high mobility group box |
77331 |
0.11 |
chr12_88910878_88911055 | 8.16 |
Nrxn3 |
neurexin III |
42424 |
0.19 |
chr13_83719614_83720062 | 8.13 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
1543 |
0.29 |
chr13_116497636_116498069 | 8.10 |
Gm47912 |
predicted gene, 47912 |
136158 |
0.05 |
chr13_105250811_105251272 | 8.08 |
Rnf180 |
ring finger protein 180 |
19998 |
0.22 |
chr11_33670175_33670394 | 8.08 |
Kcnip1 |
Kv channel-interacting protein 1 |
10287 |
0.18 |
chr7_109191034_109191228 | 8.06 |
Lmo1 |
LIM domain only 1 |
15924 |
0.17 |
chr8_26748101_26748406 | 8.05 |
Gm45646 |
predicted gene 45646 |
12308 |
0.18 |
chr13_59092007_59092498 | 8.04 |
4930415C11Rik |
RIKEN cDNA 4930415C11 gene |
8159 |
0.17 |
chr6_40024235_40024578 | 7.99 |
Gm37995 |
predicted gene, 37995 |
2488 |
0.33 |
chr3_138906418_138907063 | 7.94 |
Tspan5 |
tetraspanin 5 |
46247 |
0.14 |
chr11_32008295_32008467 | 7.94 |
Nsg2 |
neuron specific gene family member 2 |
7879 |
0.22 |
chr10_71857545_71857948 | 7.93 |
Gm22937 |
predicted gene, 22937 |
40290 |
0.15 |
chr8_122745406_122745762 | 7.80 |
C230057M02Rik |
RIKEN cDNA C230057M02 gene |
6741 |
0.11 |
chr4_143045184_143045590 | 7.80 |
6330411D24Rik |
RIKEN cDNA 6330411D24 gene |
28379 |
0.19 |
chr10_119878487_119878704 | 7.79 |
Grip1os1 |
glutamate receptor interacting protein 1, opposite strand 1 |
26205 |
0.19 |
chr12_85151401_85151685 | 7.78 |
Rps6kl1 |
ribosomal protein S6 kinase-like 1 |
279 |
0.85 |
chr4_110120761_110121239 | 7.76 |
Elavl4 |
ELAV like RNA binding protein 4 |
102148 |
0.07 |
chr12_39956297_39956455 | 7.75 |
Gm18939 |
predicted gene, 18939 |
5744 |
0.21 |
chr16_77536761_77537333 | 7.73 |
Gm36963 |
predicted gene, 36963 |
2835 |
0.18 |
chr14_111677048_111677213 | 7.67 |
Slitrk5 |
SLIT and NTRK-like family, member 5 |
1281 |
0.5 |
chr2_142589917_142590168 | 7.66 |
Rbmx2-ps |
RNA binding motif protein, X-linked 2, pseudogene |
13114 |
0.22 |
chr5_81359614_81359973 | 7.59 |
Adgrl3 |
adhesion G protein-coupled receptor L3 |
49768 |
0.18 |
chr8_123892085_123892528 | 7.52 |
Acta1 |
actin, alpha 1, skeletal muscle |
2445 |
0.15 |
chr9_13652356_13652901 | 7.49 |
Maml2 |
mastermind like transcriptional coactivator 2 |
9832 |
0.2 |
chr6_149408432_149409129 | 7.46 |
Bicd1 |
BICD cargo adaptor 1 |
106 |
0.95 |
chr10_58227289_58228680 | 7.45 |
Gm10807 |
predicted gene 10807 |
667 |
0.56 |
chrX_143931434_143931656 | 7.42 |
Dcx |
doublecortin |
1505 |
0.52 |
chr2_63184016_63185120 | 7.38 |
Kcnh7 |
potassium voltage-gated channel, subfamily H (eag-related), member 7 |
281 |
0.95 |
chr2_117429257_117429408 | 7.34 |
Gm13982 |
predicted gene 13982 |
11635 |
0.27 |
chr11_24129398_24130415 | 7.31 |
Bcl11a |
B cell CLL/lymphoma 11A (zinc finger protein) |
12473 |
0.15 |
chr17_89090010_89090391 | 7.27 |
Fshr |
follicle stimulating hormone receptor |
110475 |
0.07 |
chr11_32158171_32158538 | 7.24 |
Gm12109 |
predicted gene 12109 |
26651 |
0.12 |
chr6_26440523_26440872 | 7.23 |
Gm24691 |
predicted gene, 24691 |
19733 |
0.3 |
chr18_25681080_25681411 | 7.20 |
0710001A04Rik |
RIKEN cDNA 0710001A04 gene |
32525 |
0.2 |
chr16_81202676_81202893 | 7.19 |
Ncam2 |
neural cell adhesion molecule 2 |
2027 |
0.43 |
chr19_36534720_36535517 | 7.19 |
Hectd2 |
HECT domain E3 ubiquitin protein ligase 2 |
19521 |
0.2 |
chr16_74397266_74397471 | 7.19 |
Robo2 |
roundabout guidance receptor 2 |
13544 |
0.25 |
chr1_149896512_149896818 | 7.19 |
Pla2g4a |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
5534 |
0.26 |
chr14_119513370_119513775 | 7.09 |
Gm6212 |
predicted gene 6212 |
130440 |
0.05 |
chr3_137737517_137737704 | 7.09 |
Gm25080 |
predicted gene, 25080 |
21952 |
0.13 |
chr3_118626529_118626766 | 7.06 |
Dpyd |
dihydropyrimidine dehydrogenase |
64461 |
0.11 |
chrX_166344291_166344543 | 7.05 |
Gpm6b |
glycoprotein m6b |
275 |
0.93 |
chr18_64265188_64265726 | 7.05 |
St8sia3 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3 |
529 |
0.73 |
chr13_84059669_84060031 | 7.04 |
Gm17750 |
predicted gene, 17750 |
4922 |
0.24 |
chr12_81033728_81034006 | 7.00 |
Smoc1 |
SPARC related modular calcium binding 1 |
7039 |
0.21 |
chr9_102235369_102235971 | 6.99 |
Gm37260 |
predicted gene, 37260 |
38066 |
0.14 |
chr5_88583308_88583633 | 6.98 |
Rufy3 |
RUN and FYVE domain containing 3 |
43 |
0.97 |
chr14_118230141_118230337 | 6.96 |
Gm4675 |
predicted gene 4675 |
5993 |
0.14 |
chr12_44462981_44463367 | 6.95 |
Nrcam |
neuronal cell adhesion molecule |
6514 |
0.25 |
chr1_63763917_63764316 | 6.95 |
4933402D24Rik |
RIKEN cDNA 4933402D24 gene |
5151 |
0.18 |
chr9_89496663_89497009 | 6.93 |
Gm47403 |
predicted gene, 47403 |
63548 |
0.11 |
chr3_3832009_3832194 | 6.90 |
Gm2071 |
predicted gene 2071 |
2817 |
0.34 |
chr2_37818802_37819252 | 6.87 |
Crb2 |
crumbs family member 2 |
23858 |
0.18 |
chr10_122931607_122932575 | 6.85 |
Ppm1h |
protein phosphatase 1H (PP2C domain containing) |
36723 |
0.14 |
chr7_144628071_144628674 | 6.83 |
Ano1 |
anoctamin 1, calcium activated chloride channel |
8789 |
0.19 |
chrX_130502773_130502924 | 6.82 |
Gm14987 |
predicted gene 14987 |
10941 |
0.22 |
chr9_91365711_91366045 | 6.81 |
Zic1 |
zinc finger protein of the cerebellum 1 |
68 |
0.95 |
chr2_21060109_21060286 | 6.78 |
Gm13376 |
predicted gene 13376 |
36902 |
0.16 |
chr3_134237027_134237200 | 6.77 |
Cxxc4 |
CXXC finger 4 |
293 |
0.85 |
chr8_71727942_71728505 | 6.76 |
Fcho1 |
FCH domain only 1 |
2507 |
0.15 |
chr14_68355462_68355920 | 6.76 |
Gm31227 |
predicted gene, 31227 |
105940 |
0.06 |
chr13_34129793_34130880 | 6.76 |
Tubb2b |
tubulin, beta 2B class IIB |
18 |
0.96 |
chr10_11082248_11082420 | 6.76 |
Grm1 |
glutamate receptor, metabotropic 1 |
22 |
0.98 |
chr6_13920866_13921041 | 6.76 |
Gm44412 |
predicted gene, 44412 |
7505 |
0.22 |
chr12_50191241_50191439 | 6.71 |
Gm40418 |
predicted gene, 40418 |
71031 |
0.14 |
chrX_38313231_38313611 | 6.71 |
Atp1b4 |
ATPase, (Na+)/K+ transporting, beta 4 polypeptide |
2763 |
0.23 |
chr4_55294488_55294771 | 6.70 |
Gm25419 |
predicted gene, 25419 |
5216 |
0.16 |
chr6_144251546_144251744 | 6.69 |
Sox5 |
SRY (sex determining region Y)-box 5 |
42077 |
0.21 |
chr16_35613873_35614640 | 6.68 |
Gm5963 |
predicted pseudogene 5963 |
40700 |
0.13 |
chr16_63091747_63091940 | 6.68 |
Gm49621 |
predicted gene, 49621 |
19847 |
0.25 |
chr3_5348544_5348711 | 6.67 |
Zfhx4 |
zinc finger homeodomain 4 |
106955 |
0.07 |
chr5_84848501_84849167 | 6.67 |
Gm21006 |
predicted gene, 21006 |
18011 |
0.3 |
chr5_30712274_30713396 | 6.66 |
Dpysl5 |
dihydropyrimidinase-like 5 |
934 |
0.49 |
chr3_50014505_50014710 | 6.65 |
Gm37854 |
predicted gene, 37854 |
12635 |
0.22 |
chr15_60967833_60968237 | 6.65 |
Gm48951 |
predicted gene, 48951 |
29399 |
0.17 |
chr4_91399584_91399766 | 6.64 |
Elavl2 |
ELAV like RNA binding protein 1 |
301 |
0.92 |
chr2_130283847_130284573 | 6.63 |
Idh3b |
isocitrate dehydrogenase 3 (NAD+) beta |
205 |
0.85 |
chr2_66178605_66178756 | 6.61 |
Gm13618 |
predicted gene 13618 |
9156 |
0.18 |
chr13_73117780_73117978 | 6.61 |
Rpl31-ps2 |
ribosomal protein L31, pseudogene 2 |
115516 |
0.06 |
chr3_94483811_94484095 | 6.60 |
Celf3 |
CUGBP, Elav-like family member 3 |
374 |
0.71 |
chr2_30737839_30738040 | 6.58 |
Mir3089 |
microRNA 3089 |
16729 |
0.13 |
chr8_43356457_43356690 | 6.58 |
Gm22986 |
predicted gene, 22986 |
21402 |
0.21 |
chr8_58912252_58913386 | 6.58 |
Galntl6 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6 |
179 |
0.83 |
chr14_24550971_24551440 | 6.56 |
Rps24 |
ribosomal protein S24 |
60056 |
0.09 |
chr2_13178025_13178325 | 6.55 |
Gm37780 |
predicted gene, 37780 |
14552 |
0.2 |
chr5_97200777_97200944 | 6.54 |
Gm2861 |
predicted gene 2861 |
5274 |
0.23 |
chrX_94462540_94462871 | 6.50 |
AL627302.1 |
melanoma antigen family D, 4 pseudogene |
2566 |
0.18 |
chr17_44398035_44398193 | 6.49 |
Gm49872 |
predicted gene, 49872 |
30211 |
0.23 |
chr18_78455617_78455793 | 6.47 |
4931439C15Rik |
RIKEN cDNA 4931439C15 gene |
21173 |
0.24 |
chr11_24286671_24286960 | 6.47 |
Gm12065 |
predicted gene 12065 |
84191 |
0.08 |
chr5_97195267_97195639 | 6.46 |
Gm2861 |
predicted gene 2861 |
133 |
0.97 |
chr2_105674521_105675719 | 6.44 |
Pax6 |
paired box 6 |
11 |
0.97 |
chr1_179106487_179106660 | 6.43 |
Smyd3 |
SET and MYND domain containing 3 |
117228 |
0.06 |
chr1_89739148_89739333 | 6.42 |
Agap1 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 |
49923 |
0.13 |
chr13_20512712_20512880 | 6.42 |
Gm47657 |
predicted gene, 47657 |
8001 |
0.18 |
chr15_36967359_36968246 | 6.42 |
Gm34590 |
predicted gene, 34590 |
28938 |
0.13 |
chr8_4216526_4217378 | 6.40 |
Prr36 |
proline rich 36 |
40 |
0.94 |
chr7_78190922_78191313 | 6.40 |
Ntrk3 |
neurotrophic tyrosine kinase, receptor, type 3 |
1626 |
0.44 |
chrX_94450616_94450945 | 6.37 |
Gm24595 |
predicted gene, 24595 |
4339 |
0.14 |
chr8_61452047_61452198 | 6.37 |
Cbr4 |
carbonyl reductase 4 |
35612 |
0.16 |
chr5_4394740_4394937 | 6.35 |
Mterf1b |
mitochondrial transcription termination factor 1b |
202471 |
0.02 |
chr13_83725339_83725530 | 6.34 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
2672 |
0.18 |
chr11_32001599_32001931 | 6.34 |
Nsg2 |
neuron specific gene family member 2 |
1263 |
0.5 |
chr8_64691836_64692235 | 6.33 |
Cpe |
carboxypeptidase E |
1019 |
0.52 |
chr4_109343206_109343384 | 6.33 |
Eps15 |
epidermal growth factor receptor pathway substrate 15 |
42 |
0.98 |
chr8_14381522_14381725 | 6.31 |
Dlgap2 |
DLG associated protein 2 |
111 |
0.98 |
chr4_117909147_117909425 | 6.31 |
Ipo13 |
importin 13 |
5419 |
0.11 |
chr2_101172759_101173110 | 6.31 |
Gm20693 |
predicted gene 20693 |
397690 |
0.01 |
chr14_100133178_100133329 | 6.30 |
Klf12 |
Kruppel-like factor 12 |
16511 |
0.24 |
chr6_23876800_23877084 | 6.29 |
Cadps2 |
Ca2+-dependent activator protein for secretion 2 |
37521 |
0.2 |
chr10_57822502_57822860 | 6.27 |
Smpdl3a |
sphingomyelin phosphodiesterase, acid-like 3A |
28113 |
0.17 |
chr6_107462424_107462843 | 6.26 |
Gm27690 |
predicted gene, 27690 |
13689 |
0.22 |
chr3_86745782_86746167 | 6.26 |
Gm37876 |
predicted gene, 37876 |
32679 |
0.16 |
chr7_105786596_105787077 | 6.25 |
Dchs1 |
dachsous cadherin related 1 |
716 |
0.5 |
chr13_59092821_59093346 | 6.24 |
4930415C11Rik |
RIKEN cDNA 4930415C11 gene |
8990 |
0.17 |
chr11_37650264_37650415 | 6.23 |
Gm12128 |
predicted gene 12128 |
8650 |
0.34 |
chr15_12093297_12093665 | 6.22 |
Gm34759 |
predicted gene, 34759 |
8284 |
0.16 |
chr1_25229305_25229684 | 6.21 |
Adgrb3 |
adhesion G protein-coupled receptor B3 |
394 |
0.81 |
chr9_43934021_43934345 | 6.19 |
Gm23326 |
predicted gene, 23326 |
28181 |
0.11 |
chr10_46072283_46072434 | 6.16 |
Gm35430 |
predicted gene, 35430 |
156281 |
0.04 |
chr3_88232209_88232744 | 6.15 |
Gm3764 |
predicted gene 3764 |
3693 |
0.1 |
chr16_25016242_25016817 | 6.11 |
A230028O05Rik |
RIKEN cDNA A230028O05 gene |
43110 |
0.19 |
chr6_137252172_137252972 | 6.10 |
Ptpro |
protein tyrosine phosphatase, receptor type, O |
107 |
0.98 |
chr6_16727609_16727777 | 6.09 |
Gm36669 |
predicted gene, 36669 |
49831 |
0.17 |
chr18_21654663_21654851 | 6.08 |
Klhl14 |
kelch-like 14 |
39 |
0.98 |
chr8_70840798_70841569 | 6.08 |
Arrdc2 |
arrestin domain containing 2 |
1463 |
0.19 |
chr8_32883706_32884108 | 6.03 |
Nrg1 |
neuregulin 1 |
45 |
0.99 |
chr9_91384764_91384952 | 6.03 |
Zic4 |
zinc finger protein of the cerebellum 4 |
2448 |
0.18 |
chr16_9672472_9672666 | 6.01 |
Grin2a |
glutamate receptor, ionotropic, NMDA2A (epsilon 1) |
124764 |
0.06 |
chr6_121402489_121402653 | 6.01 |
Slc6a12 |
solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12 |
43606 |
0.12 |
chr17_80553317_80553537 | 6.01 |
Gm33373 |
predicted gene, 33373 |
37 |
0.98 |
chr18_60925808_60926037 | 5.99 |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
197 |
0.92 |
chr1_67366568_67366878 | 5.99 |
Gm26342 |
predicted gene, 26342 |
109499 |
0.06 |
chr7_62046082_62046717 | 5.98 |
Mir344f |
microRNA Mir344f |
151 |
0.94 |
chr8_128528590_128528913 | 5.96 |
Gm9204 |
predicted gene 9204 |
105185 |
0.06 |
chr8_45557893_45558414 | 5.96 |
Gm45458 |
predicted gene 45458 |
18038 |
0.16 |
chr9_114026283_114026988 | 5.94 |
Fbxl2 |
F-box and leucine-rich repeat protein 2 |
91 |
0.97 |
chr5_13314097_13314325 | 5.92 |
Sema3a |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
82573 |
0.09 |
chr10_38357833_38358251 | 5.92 |
Gm48197 |
predicted gene, 48197 |
44196 |
0.17 |
chr3_26146228_26146427 | 5.90 |
Nlgn1 |
neuroligin 1 |
6980 |
0.33 |
chr2_145404885_145405071 | 5.90 |
Gm22731 |
predicted gene, 22731 |
52135 |
0.14 |
chr15_99724323_99725930 | 5.89 |
Cox14 |
cytochrome c oxidase assembly protein 14 |
521 |
0.41 |
chr13_6473899_6474386 | 5.88 |
2900042G08Rik |
RIKEN cDNA 2900042G08 gene |
56453 |
0.12 |
chr4_13750402_13750908 | 5.87 |
Runx1t1 |
RUNX1 translocation partner 1 |
642 |
0.82 |
chr13_14522109_14522562 | 5.87 |
Gm30893 |
predicted gene, 30893 |
181 |
0.78 |
chr8_86438259_86438704 | 5.87 |
Abcc12 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 12 |
96266 |
0.07 |
chr12_33341296_33341797 | 5.87 |
Atxn7l1 |
ataxin 7-like 1 |
3759 |
0.23 |
chr8_61515742_61515914 | 5.87 |
Palld |
palladin, cytoskeletal associated protein |
72 |
0.98 |
chr1_57847186_57847358 | 5.86 |
Spats2l |
spermatogenesis associated, serine-rich 2-like |
1701 |
0.45 |
chrX_72895479_72896098 | 5.84 |
Cetn2 |
centrin 2 |
21068 |
0.13 |
chr11_69410509_69411506 | 5.84 |
Kdm6b |
KDM1 lysine (K)-specific demethylase 6B |
2668 |
0.12 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.2 | 21.7 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
4.9 | 14.7 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
4.6 | 13.8 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
3.7 | 11.2 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
3.7 | 11.1 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
3.4 | 13.4 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
3.3 | 10.0 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
3.2 | 12.9 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
3.1 | 3.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
2.9 | 8.8 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
2.7 | 8.2 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
2.7 | 8.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
2.7 | 8.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
2.6 | 10.6 | GO:0006538 | glutamate catabolic process(GO:0006538) |
2.6 | 2.6 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
2.6 | 18.5 | GO:0016198 | axon choice point recognition(GO:0016198) |
2.6 | 7.7 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
2.5 | 7.6 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
2.5 | 25.3 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
2.5 | 7.6 | GO:1990034 | calcium ion export from cell(GO:1990034) |
2.4 | 7.1 | GO:0097503 | sialylation(GO:0097503) |
2.3 | 11.3 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
2.2 | 18.0 | GO:0021860 | pyramidal neuron development(GO:0021860) |
2.2 | 8.6 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
2.1 | 49.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
2.1 | 27.4 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
2.1 | 6.3 | GO:0072221 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
2.0 | 3.9 | GO:0071873 | response to norepinephrine(GO:0071873) |
2.0 | 7.9 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.9 | 1.9 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
1.9 | 7.7 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.9 | 5.7 | GO:0030070 | insulin processing(GO:0030070) |
1.9 | 13.0 | GO:0097264 | self proteolysis(GO:0097264) |
1.8 | 7.3 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
1.8 | 5.3 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.8 | 1.8 | GO:2000481 | positive regulation of cAMP-dependent protein kinase activity(GO:2000481) |
1.7 | 1.7 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
1.7 | 5.2 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
1.7 | 6.9 | GO:0046959 | habituation(GO:0046959) |
1.7 | 5.1 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
1.7 | 8.5 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
1.7 | 5.0 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
1.7 | 5.0 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
1.7 | 6.6 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
1.6 | 4.8 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
1.6 | 4.8 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
1.6 | 4.7 | GO:1901656 | glycoside transport(GO:1901656) |
1.5 | 4.6 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
1.5 | 6.1 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
1.5 | 3.0 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
1.5 | 7.5 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
1.5 | 1.5 | GO:0072309 | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
1.5 | 4.4 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
1.5 | 4.4 | GO:0010040 | response to iron(II) ion(GO:0010040) |
1.5 | 5.8 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
1.5 | 2.9 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.4 | 5.8 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
1.4 | 4.3 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
1.4 | 8.6 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
1.4 | 11.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.4 | 5.6 | GO:1901660 | calcium ion export(GO:1901660) |
1.4 | 4.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
1.4 | 4.1 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
1.3 | 4.0 | GO:0006553 | lysine metabolic process(GO:0006553) |
1.3 | 6.7 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
1.3 | 1.3 | GO:0090493 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
1.3 | 6.6 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
1.3 | 6.5 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
1.3 | 3.9 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
1.3 | 3.8 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.3 | 3.8 | GO:0099612 | protein localization to paranode region of axon(GO:0002175) protein localization to axon(GO:0099612) |
1.3 | 3.8 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
1.3 | 2.5 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
1.2 | 13.7 | GO:0048268 | clathrin coat assembly(GO:0048268) |
1.2 | 9.6 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
1.2 | 7.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
1.2 | 3.6 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
1.2 | 4.8 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
1.2 | 7.1 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
1.2 | 3.5 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
1.1 | 1.1 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
1.1 | 1.1 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
1.1 | 4.5 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
1.1 | 1.1 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
1.1 | 2.2 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
1.1 | 3.3 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
1.1 | 1.1 | GO:0097106 | postsynaptic density organization(GO:0097106) postsynaptic density assembly(GO:0097107) |
1.1 | 3.3 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
1.1 | 3.3 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
1.1 | 5.5 | GO:0060278 | regulation of ovulation(GO:0060278) |
1.1 | 1.1 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
1.1 | 3.3 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.1 | 3.3 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
1.1 | 4.3 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
1.1 | 4.3 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
1.1 | 3.2 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
1.1 | 4.2 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
1.1 | 16.9 | GO:0060074 | synapse maturation(GO:0060074) |
1.1 | 3.2 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
1.1 | 6.3 | GO:0006559 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
1.1 | 3.2 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
1.0 | 5.2 | GO:0051013 | microtubule severing(GO:0051013) |
1.0 | 2.1 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
1.0 | 2.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
1.0 | 3.1 | GO:0006868 | glutamine transport(GO:0006868) |
1.0 | 9.3 | GO:0050957 | equilibrioception(GO:0050957) |
1.0 | 3.1 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
1.0 | 3.0 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
1.0 | 4.0 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
1.0 | 2.0 | GO:0008228 | opsonization(GO:0008228) |
1.0 | 2.0 | GO:0045963 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
1.0 | 7.9 | GO:0008090 | retrograde axonal transport(GO:0008090) |
1.0 | 4.0 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
1.0 | 1.0 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
1.0 | 2.9 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
1.0 | 3.9 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
1.0 | 5.8 | GO:0006642 | triglyceride mobilization(GO:0006642) |
1.0 | 14.5 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
1.0 | 10.6 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
1.0 | 16.2 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.9 | 2.8 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.9 | 3.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.9 | 1.9 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.9 | 3.8 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.9 | 1.9 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.9 | 0.9 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.9 | 13.1 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.9 | 2.8 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.9 | 2.8 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.9 | 1.8 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.9 | 2.8 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.9 | 2.7 | GO:1902837 | amino acid import into cell(GO:1902837) |
0.9 | 1.8 | GO:0043622 | cortical microtubule organization(GO:0043622) |
0.9 | 2.7 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.9 | 2.7 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.9 | 0.9 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.9 | 2.7 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.9 | 1.8 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.9 | 0.9 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.9 | 2.7 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.9 | 6.2 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.9 | 1.8 | GO:0061743 | motor learning(GO:0061743) |
0.9 | 5.3 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.9 | 2.7 | GO:0061346 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
0.9 | 7.9 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.9 | 2.6 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.9 | 2.6 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.9 | 3.5 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.9 | 5.2 | GO:0071625 | vocalization behavior(GO:0071625) |
0.9 | 5.2 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
0.9 | 3.5 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.9 | 4.3 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.9 | 4.3 | GO:0080009 | mRNA methylation(GO:0080009) |
0.9 | 12.9 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.9 | 2.6 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.9 | 2.6 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.9 | 1.7 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.8 | 1.7 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.8 | 5.1 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.8 | 4.2 | GO:0071420 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
0.8 | 2.5 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.8 | 2.5 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.8 | 4.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.8 | 4.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.8 | 1.6 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.8 | 1.6 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.8 | 2.4 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.8 | 4.1 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.8 | 3.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.8 | 3.2 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
0.8 | 4.8 | GO:0006983 | ER overload response(GO:0006983) |
0.8 | 1.6 | GO:0090382 | phagosome maturation(GO:0090382) |
0.8 | 2.4 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.8 | 4.8 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.8 | 0.8 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.8 | 5.6 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.8 | 3.2 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.8 | 4.0 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.8 | 2.4 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.8 | 6.3 | GO:0070269 | pyroptosis(GO:0070269) |
0.8 | 9.5 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.8 | 2.4 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.8 | 1.6 | GO:0071472 | cellular response to salt stress(GO:0071472) |
0.8 | 2.4 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.8 | 2.4 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.8 | 0.8 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.8 | 2.4 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.8 | 1.6 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.8 | 0.8 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.8 | 2.4 | GO:0072017 | distal tubule development(GO:0072017) |
0.8 | 7.1 | GO:0021756 | striatum development(GO:0021756) |
0.8 | 2.3 | GO:0090135 | actin filament branching(GO:0090135) |
0.8 | 2.3 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.8 | 4.7 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.8 | 3.9 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.8 | 2.3 | GO:0048069 | eye pigmentation(GO:0048069) |
0.8 | 3.1 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.8 | 6.2 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.8 | 2.3 | GO:0006222 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.8 | 2.3 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.8 | 4.6 | GO:0042048 | olfactory behavior(GO:0042048) |
0.8 | 0.8 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.8 | 4.6 | GO:0060179 | male mating behavior(GO:0060179) |
0.8 | 16.6 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.8 | 0.8 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.7 | 3.0 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.7 | 1.5 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.7 | 0.7 | GO:0009642 | response to light intensity(GO:0009642) |
0.7 | 4.4 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.7 | 2.2 | GO:0099623 | cardiac muscle cell membrane repolarization(GO:0099622) regulation of cardiac muscle cell membrane repolarization(GO:0099623) |
0.7 | 0.7 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.7 | 2.2 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.7 | 2.9 | GO:0009211 | pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) |
0.7 | 2.9 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.7 | 0.7 | GO:1901524 | regulation of macromitophagy(GO:1901524) |
0.7 | 0.7 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.7 | 5.1 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.7 | 2.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.7 | 5.0 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.7 | 0.7 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.7 | 2.1 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.7 | 2.9 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.7 | 0.7 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) |
0.7 | 2.1 | GO:0030035 | microspike assembly(GO:0030035) |
0.7 | 3.5 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.7 | 0.7 | GO:0060166 | olfactory pit development(GO:0060166) |
0.7 | 3.5 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.7 | 1.4 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.7 | 2.8 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.7 | 6.2 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.7 | 0.7 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.7 | 2.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.7 | 4.1 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.7 | 1.4 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.7 | 1.4 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
0.7 | 4.7 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.7 | 2.7 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.7 | 4.0 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.7 | 3.3 | GO:0090383 | phagosome acidification(GO:0090383) |
0.7 | 2.0 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.7 | 33.4 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.7 | 3.3 | GO:0015791 | polyol transport(GO:0015791) |
0.7 | 2.6 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.7 | 2.0 | GO:0030421 | defecation(GO:0030421) |
0.6 | 1.3 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.6 | 1.3 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.6 | 0.6 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.6 | 5.2 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.6 | 3.2 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.6 | 1.3 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.6 | 1.3 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.6 | 1.3 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.6 | 0.6 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.6 | 1.9 | GO:2000850 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.6 | 1.3 | GO:0022030 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.6 | 3.1 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.6 | 46.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.6 | 3.1 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.6 | 0.6 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.6 | 2.5 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.6 | 3.7 | GO:0016246 | RNA interference(GO:0016246) |
0.6 | 0.6 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.6 | 8.7 | GO:0010842 | retina layer formation(GO:0010842) |
0.6 | 4.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.6 | 9.2 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.6 | 1.8 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.6 | 1.2 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.6 | 1.2 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.6 | 8.4 | GO:0003407 | neural retina development(GO:0003407) |
0.6 | 3.0 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.6 | 1.8 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.6 | 4.8 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.6 | 3.0 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.6 | 3.6 | GO:0042069 | regulation of catecholamine metabolic process(GO:0042069) |
0.6 | 0.6 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.6 | 0.6 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
0.6 | 2.4 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.6 | 0.6 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.6 | 2.3 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.6 | 1.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.6 | 2.3 | GO:0033762 | response to glucagon(GO:0033762) |
0.6 | 1.2 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.6 | 1.7 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.6 | 1.7 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.6 | 1.7 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.6 | 3.5 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.6 | 2.9 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.6 | 14.4 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.6 | 3.4 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.6 | 4.6 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.6 | 1.1 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.6 | 2.3 | GO:2000765 | regulation of cytoplasmic translation(GO:2000765) |
0.6 | 1.7 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.6 | 2.3 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.6 | 1.7 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.6 | 2.2 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.6 | 2.8 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.6 | 2.2 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.6 | 1.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.5 | 0.5 | GO:0010873 | regulation of cholesterol esterification(GO:0010872) positive regulation of cholesterol esterification(GO:0010873) |
0.5 | 1.6 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.5 | 0.5 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.5 | 7.6 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.5 | 1.6 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.5 | 3.2 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.5 | 1.6 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.5 | 1.6 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.5 | 3.7 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.5 | 3.1 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.5 | 1.6 | GO:0032898 | neurotrophin production(GO:0032898) |
0.5 | 1.6 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.5 | 1.0 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.5 | 2.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.5 | 1.6 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.5 | 1.6 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.5 | 1.0 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.5 | 2.1 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.5 | 0.5 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.5 | 2.0 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.5 | 2.0 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.5 | 5.6 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.5 | 1.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.5 | 0.5 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.5 | 1.5 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.5 | 3.0 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.5 | 2.0 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.5 | 2.0 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.5 | 0.5 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.5 | 2.5 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.5 | 1.5 | GO:0048664 | neuron fate determination(GO:0048664) |
0.5 | 2.0 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.5 | 2.9 | GO:0015074 | DNA integration(GO:0015074) |
0.5 | 2.9 | GO:0051256 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.5 | 1.5 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.5 | 1.9 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.5 | 2.9 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.5 | 1.4 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.5 | 0.5 | GO:0032672 | regulation of interleukin-3 production(GO:0032672) |
0.5 | 1.0 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.5 | 2.9 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.5 | 0.5 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.5 | 3.3 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.5 | 1.4 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.5 | 4.3 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.5 | 1.9 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.5 | 1.9 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.5 | 0.5 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.5 | 1.4 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.5 | 2.4 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
0.5 | 0.5 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.5 | 1.4 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.5 | 0.9 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.5 | 0.5 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.5 | 0.5 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.5 | 1.4 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.5 | 0.9 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.5 | 1.8 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.5 | 2.8 | GO:0002576 | platelet degranulation(GO:0002576) |
0.5 | 0.9 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.5 | 1.8 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.5 | 1.8 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.5 | 1.8 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.5 | 0.5 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.5 | 2.3 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.4 | 0.4 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.4 | 7.1 | GO:0044804 | nucleophagy(GO:0044804) |
0.4 | 2.2 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.4 | 2.6 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.4 | 4.8 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.4 | 0.9 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.4 | 0.4 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.4 | 2.6 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.4 | 2.1 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.4 | 0.8 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.4 | 0.8 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.4 | 1.7 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.4 | 2.5 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.4 | 0.4 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.4 | 0.4 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.4 | 0.8 | GO:0042662 | negative regulation of mesodermal cell fate specification(GO:0042662) |
0.4 | 0.8 | GO:0030242 | pexophagy(GO:0030242) |
0.4 | 0.8 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.4 | 2.5 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.4 | 0.4 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.4 | 1.2 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.4 | 0.4 | GO:0061010 | gall bladder development(GO:0061010) |
0.4 | 2.9 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.4 | 3.3 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.4 | 3.3 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.4 | 6.1 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.4 | 1.2 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.4 | 0.8 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
0.4 | 1.2 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.4 | 2.0 | GO:0043987 | histone-serine phosphorylation(GO:0035404) histone H3-S10 phosphorylation(GO:0043987) |
0.4 | 0.4 | GO:0035973 | aggrephagy(GO:0035973) |
0.4 | 1.2 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.4 | 0.8 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
0.4 | 0.4 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.4 | 2.0 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.4 | 2.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.4 | 0.8 | GO:0006586 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.4 | 0.8 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.4 | 0.4 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.4 | 1.6 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.4 | 1.2 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.4 | 0.8 | GO:0014028 | notochord formation(GO:0014028) |
0.4 | 2.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.4 | 5.1 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
0.4 | 0.4 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.4 | 1.9 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.4 | 0.8 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.4 | 0.4 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.4 | 1.9 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.4 | 0.8 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.4 | 1.1 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.4 | 1.5 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.4 | 4.2 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.4 | 1.9 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.4 | 0.8 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.4 | 3.8 | GO:0060004 | reflex(GO:0060004) |
0.4 | 1.1 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.4 | 0.4 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.4 | 1.9 | GO:0015884 | folic acid transport(GO:0015884) |
0.4 | 0.4 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.4 | 1.1 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.4 | 2.2 | GO:0007340 | acrosome reaction(GO:0007340) |
0.4 | 5.9 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.4 | 1.5 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.4 | 2.2 | GO:0001964 | startle response(GO:0001964) |
0.4 | 1.5 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.4 | 1.5 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.4 | 0.7 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.4 | 0.4 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.4 | 1.1 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.4 | 1.4 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.4 | 3.5 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.4 | 2.1 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.4 | 2.8 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.3 | 2.8 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.3 | 2.1 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
0.3 | 1.0 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.3 | 0.7 | GO:0072178 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.3 | 3.8 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.3 | 1.0 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.3 | 1.4 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.3 | 1.0 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.3 | 3.4 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.3 | 1.3 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.3 | 1.0 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.3 | 1.0 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.3 | 1.3 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.3 | 1.0 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.3 | 1.0 | GO:0046618 | drug export(GO:0046618) |
0.3 | 3.0 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.3 | 1.0 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.3 | 0.6 | GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
0.3 | 1.0 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.3 | 3.2 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.3 | 0.6 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.3 | 0.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.3 | 2.2 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.3 | 0.9 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.3 | 0.6 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.3 | 0.6 | GO:0090169 | regulation of spindle assembly(GO:0090169) |
0.3 | 1.6 | GO:1900094 | nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.3 | 3.4 | GO:0036065 | fucosylation(GO:0036065) |
0.3 | 0.9 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.3 | 0.6 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.3 | 0.3 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.3 | 1.2 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
0.3 | 2.8 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.3 | 1.9 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.3 | 0.6 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
0.3 | 0.6 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.3 | 0.6 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.3 | 3.4 | GO:0072662 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.3 | 3.4 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.3 | 0.9 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.3 | 2.8 | GO:0045738 | negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
0.3 | 0.6 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
0.3 | 1.8 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.3 | 1.2 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.3 | 0.9 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.3 | 0.9 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.3 | 4.8 | GO:0071242 | cellular response to ammonium ion(GO:0071242) |
0.3 | 0.6 | GO:0032202 | telomere assembly(GO:0032202) |
0.3 | 1.8 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.3 | 5.1 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.3 | 2.4 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.3 | 0.9 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.3 | 0.9 | GO:0015888 | thiamine transport(GO:0015888) |
0.3 | 0.6 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.3 | 0.6 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.3 | 4.4 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.3 | 0.6 | GO:0003032 | detection of oxygen(GO:0003032) |
0.3 | 2.3 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.3 | 0.3 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.3 | 0.6 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.3 | 1.1 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.3 | 1.4 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.3 | 0.3 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.3 | 0.6 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.3 | 1.4 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.3 | 0.6 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.3 | 0.3 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.3 | 2.3 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.3 | 0.8 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.3 | 1.7 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.3 | 0.6 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.3 | 1.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.3 | 1.1 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.3 | 1.1 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.3 | 0.6 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.3 | 1.7 | GO:0080111 | DNA demethylation(GO:0080111) |
0.3 | 0.8 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.3 | 0.8 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.3 | 0.8 | GO:1904666 | regulation of ubiquitin protein ligase activity(GO:1904666) positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.3 | 2.5 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.3 | 1.1 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.3 | 1.1 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.3 | 0.8 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.3 | 1.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.3 | 0.5 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.3 | 1.9 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.3 | 3.8 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.3 | 0.5 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.3 | 0.5 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.3 | 1.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.3 | 0.3 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.3 | 0.8 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.3 | 2.4 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.3 | 0.5 | GO:0019086 | late viral transcription(GO:0019086) |
0.3 | 0.3 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.3 | 0.8 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.3 | 0.5 | GO:0030576 | Cajal body organization(GO:0030576) |
0.3 | 1.3 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.3 | 0.3 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.3 | 0.5 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.3 | 12.4 | GO:0035773 | insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
0.3 | 0.8 | GO:0030728 | ovulation(GO:0030728) |
0.3 | 3.1 | GO:0021766 | hippocampus development(GO:0021766) |
0.3 | 1.0 | GO:0035627 | ceramide transport(GO:0035627) |
0.3 | 0.5 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
0.3 | 3.3 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.3 | 0.3 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.3 | 0.8 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.3 | 0.8 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.3 | 2.0 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.3 | 0.5 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.3 | 1.0 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.3 | 0.8 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.3 | 1.8 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.2 | 1.7 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.2 | 1.7 | GO:0051382 | kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
0.2 | 1.0 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.2 | 1.0 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.2 | 4.9 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.2 | 4.7 | GO:0019228 | neuronal action potential(GO:0019228) |
0.2 | 1.0 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.2 | 1.0 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.2 | 1.0 | GO:0031650 | regulation of heat generation(GO:0031650) |
0.2 | 6.8 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.2 | 0.5 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.2 | 3.4 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.2 | 0.5 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.2 | 0.7 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.2 | 1.2 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.2 | 0.7 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.2 | 1.0 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.2 | 3.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 2.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 0.9 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.2 | 0.7 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
0.2 | 0.2 | GO:0072566 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.2 | 1.2 | GO:0003157 | endocardium development(GO:0003157) |
0.2 | 1.2 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.2 | 0.5 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.2 | 1.6 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.2 | 0.5 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.2 | 3.5 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.2 | 0.9 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 0.7 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.2 | 0.5 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.2 | 1.8 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.2 | 0.7 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.2 | 0.7 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.2 | 1.4 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 0.2 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.2 | 3.4 | GO:0048260 | positive regulation of receptor-mediated endocytosis(GO:0048260) |
0.2 | 11.7 | GO:0007612 | learning(GO:0007612) |
0.2 | 0.4 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.2 | 0.9 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.2 | 0.2 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.2 | 0.7 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.2 | 0.9 | GO:0021794 | thalamus development(GO:0021794) |
0.2 | 0.7 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.2 | 2.4 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.2 | 2.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.2 | 0.7 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.2 | 0.7 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.2 | 0.2 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 0.2 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.2 | 0.2 | GO:0003072 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.2 | 0.4 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
0.2 | 0.4 | GO:1904970 | brush border assembly(GO:1904970) |
0.2 | 1.1 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.2 | 0.2 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.2 | 3.4 | GO:0009303 | rRNA transcription(GO:0009303) |
0.2 | 1.1 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.2 | 1.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.2 | 1.3 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.2 | 1.0 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.2 | 1.0 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.2 | 0.4 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.2 | 0.6 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.2 | 0.2 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.2 | 1.0 | GO:1904871 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.2 | 0.2 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.2 | 0.2 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.2 | 1.6 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.2 | 4.1 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.2 | 1.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.2 | 0.4 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 | 0.4 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.2 | 0.4 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.2 | 0.4 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.2 | 0.2 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.2 | 1.4 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.2 | 0.4 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.2 | 0.2 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.2 | 2.1 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.2 | 1.6 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.2 | 0.2 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.2 | 0.8 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.2 | 1.0 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.2 | 1.3 | GO:0014002 | astrocyte development(GO:0014002) |
0.2 | 0.4 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.2 | 2.1 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.2 | 1.0 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.2 | 0.6 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 1.5 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.2 | 0.2 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.2 | 1.9 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.2 | 0.4 | GO:0019532 | oxalate transport(GO:0019532) |
0.2 | 0.7 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.2 | 0.6 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.2 | 0.4 | GO:1904429 | regulation of t-circle formation(GO:1904429) |
0.2 | 0.5 | GO:0008038 | neuron recognition(GO:0008038) |
0.2 | 0.2 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.2 | 0.5 | GO:0015886 | heme transport(GO:0015886) |
0.2 | 0.5 | GO:0018410 | C-terminal protein amino acid modification(GO:0018410) |
0.2 | 0.4 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.2 | 2.9 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.2 | 0.2 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.2 | 3.2 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.2 | 1.2 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 | 0.7 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.2 | 0.4 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.2 | 0.7 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.2 | 0.7 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.2 | 0.3 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.2 | 0.3 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.2 | 2.1 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.2 | 2.2 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.2 | 1.4 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.2 | 1.0 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.2 | 0.3 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.2 | 0.2 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.2 | 0.3 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.2 | 5.3 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.2 | 0.8 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
0.2 | 1.0 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.2 | 2.0 | GO:0006415 | translational termination(GO:0006415) |
0.2 | 0.2 | GO:0086026 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
0.2 | 0.3 | GO:0035425 | autocrine signaling(GO:0035425) |
0.2 | 0.3 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.2 | 0.3 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.2 | 1.5 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.2 | 1.3 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.2 | 1.7 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.2 | 0.7 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
0.2 | 1.2 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.2 | 0.7 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.2 | 0.2 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.2 | 1.1 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.2 | 0.5 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.2 | 0.5 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.2 | 0.3 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.2 | 0.2 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.2 | 3.9 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.2 | 3.2 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.2 | 4.3 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.2 | 0.3 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.2 | 1.1 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.2 | 0.3 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.2 | 1.3 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.2 | 3.8 | GO:0034605 | cellular response to heat(GO:0034605) |
0.2 | 0.2 | GO:0010998 | regulation of translational initiation by eIF2 alpha phosphorylation(GO:0010998) |
0.2 | 1.3 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.2 | 0.5 | GO:0015824 | L-alanine transport(GO:0015808) proline transport(GO:0015824) |
0.2 | 0.8 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.2 | 0.6 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.2 | 1.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.2 | 0.2 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.2 | 1.2 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.2 | 0.5 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.2 | 0.3 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.2 | 0.3 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.2 | 0.2 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.2 | 0.2 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.2 | 1.4 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.2 | 0.5 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.2 | 0.5 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.2 | 0.3 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.2 | 0.8 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.2 | 0.3 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.2 | 1.1 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.2 | 0.3 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.2 | 0.6 | GO:0033753 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.2 | 3.9 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.2 | 0.9 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.2 | 0.9 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 0.6 | GO:0002584 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.2 | 0.2 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.2 | 0.3 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.2 | 5.0 | GO:0043039 | tRNA aminoacylation(GO:0043039) |
0.2 | 0.6 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.1 | 1.0 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 0.1 | GO:0030002 | cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) |
0.1 | 0.3 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.1 | 0.4 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
0.1 | 3.7 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.1 | 2.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.1 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.1 | 0.6 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 7.9 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 0.3 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 0.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 6.2 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.1 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.1 | 0.7 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.1 | 1.0 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.4 | GO:0000087 | mitotic M phase(GO:0000087) |
0.1 | 1.7 | GO:1902668 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
0.1 | 0.7 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 2.1 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.1 | 0.4 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 0.3 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.1 | 1.7 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.1 | 0.7 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.1 | 0.4 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.1 | 0.8 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 0.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.7 | GO:0071435 | potassium ion export(GO:0071435) |
0.1 | 0.3 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.6 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.4 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 1.8 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.1 | 0.7 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.3 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.1 | 0.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 1.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.1 | GO:0090239 | regulation of histone H4 acetylation(GO:0090239) |
0.1 | 0.9 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.1 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.1 | 0.3 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.1 | 0.8 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 0.6 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.8 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.1 | 0.3 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.1 | 0.4 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.3 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.1 | 0.5 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.6 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.1 | 0.2 | GO:2000674 | regulation of type B pancreatic cell apoptotic process(GO:2000674) |
0.1 | 0.4 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.2 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.1 | 0.9 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.1 | 1.0 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 0.2 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 3.4 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 0.4 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 | 0.4 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.1 | 0.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.5 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.1 | 0.5 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.1 | 2.1 | GO:0099643 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.1 | 1.5 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.1 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 1.5 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 0.2 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.1 | 0.2 | GO:0000237 | leptotene(GO:0000237) |
0.1 | 0.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.1 | 0.7 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.5 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.2 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 0.6 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.1 | 1.4 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 1.0 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.2 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.1 | 0.6 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.1 | 0.3 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.1 | 0.4 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.1 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.1 | 0.1 | GO:0021559 | trigeminal nerve development(GO:0021559) trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) |
0.1 | 0.4 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 0.3 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.1 | 0.9 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.1 | 0.2 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.4 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.1 | 1.7 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.2 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.1 | 1.1 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.8 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.1 | 0.5 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.5 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.1 | 0.1 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.1 | 0.8 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.1 | 0.5 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
0.1 | 0.1 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.1 | 0.7 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.8 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.1 | 0.2 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.7 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.1 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.1 | 0.3 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.1 | 0.2 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
0.1 | 0.3 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.5 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.1 | 1.0 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.1 | 2.0 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.6 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 1.0 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.1 | 0.2 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.1 | 0.2 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.1 | 1.2 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.6 | GO:1904262 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.2 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.1 | 0.1 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.1 | 7.1 | GO:0071804 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.1 | 0.3 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.1 | 0.1 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.1 | 0.1 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.1 | 0.1 | GO:0035754 | B cell chemotaxis(GO:0035754) negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.1 | 0.1 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.1 | 0.2 | GO:0036124 | histone H3-K9 dimethylation(GO:0036123) histone H3-K9 trimethylation(GO:0036124) |
0.1 | 0.1 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.1 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.1 | 0.3 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.1 | 0.1 | GO:0046051 | UTP metabolic process(GO:0046051) |
0.1 | 0.1 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.1 | 0.4 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 0.2 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.1 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.1 | 0.1 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
0.1 | 0.5 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.2 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.1 | 0.2 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.1 | 0.3 | GO:0033504 | floor plate development(GO:0033504) |
0.1 | 0.8 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.1 | 0.3 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
0.1 | 0.3 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.1 | 0.2 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.1 | 0.3 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 0.3 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 0.7 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 0.1 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.1 | 0.2 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 0.1 | GO:1902488 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.1 | 0.2 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 0.9 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 1.1 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.1 | 3.5 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
0.1 | 0.7 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.1 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.1 | 1.7 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.1 | 0.9 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.1 | 2.0 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 0.2 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 0.2 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.6 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.1 | 0.2 | GO:0022038 | corpus callosum development(GO:0022038) |
0.1 | 1.6 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.1 | 0.1 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 0.1 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
0.1 | 0.3 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 0.2 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.1 | 0.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.1 | 0.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.4 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 0.3 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.9 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.4 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 0.1 | GO:0036445 | neuronal stem cell division(GO:0036445) neuroblast division(GO:0055057) |
0.1 | 0.3 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.1 | 0.9 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
0.1 | 0.1 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.1 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.1 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.1 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.3 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.1 | 0.1 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.1 | 0.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 0.1 | GO:0014075 | response to amine(GO:0014075) |
0.1 | 0.5 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.9 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.5 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.4 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.1 | 0.6 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.2 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.1 | 0.1 | GO:0061047 | positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.1 | 0.1 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.1 | 0.1 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.1 | 0.1 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.1 | 0.1 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
0.1 | 0.1 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 1.2 | GO:0006813 | potassium ion transport(GO:0006813) |
0.1 | 1.8 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.4 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.1 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.1 | 0.1 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.1 | 0.3 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.1 | 0.3 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 0.6 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.1 | GO:0071673 | regulation of smooth muscle cell chemotaxis(GO:0071671) positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.1 | 0.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.1 | GO:0072223 | metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
0.1 | 2.3 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.2 | GO:1902572 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.1 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.1 | 0.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.5 | GO:0072422 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.1 | 0.1 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.2 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.1 | 1.1 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.1 | 0.7 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.1 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.1 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.1 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 0.1 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.1 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.0 | 0.2 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.0 | 0.0 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.0 | 0.0 | GO:0070668 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) negative regulation of mast cell apoptotic process(GO:0033026) mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.0 | 0.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.3 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.1 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.0 | 0.2 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 0.0 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
0.0 | 0.1 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.0 | 0.9 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 1.4 | GO:0042698 | ovulation cycle(GO:0042698) |
0.0 | 0.4 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.0 | 0.2 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.0 | 0.1 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.0 | 0.0 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.0 | 0.1 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.0 | 0.0 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.0 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.0 | 0.0 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.0 | 0.0 | GO:0060437 | lung growth(GO:0060437) |
0.0 | 0.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.0 | 1.7 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.1 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.0 | 0.0 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.0 | 0.1 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.0 | 0.3 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.0 | 0.2 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.4 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.1 | GO:0035809 | regulation of urine volume(GO:0035809) |
0.0 | 0.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.1 | GO:0002860 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.0 | 0.1 | GO:0070417 | cellular response to cold(GO:0070417) |
0.0 | 0.1 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.0 | 0.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.0 | GO:0045023 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) |
0.0 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.4 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.0 | 0.1 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.0 | 0.0 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.0 | 0.0 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.0 | 0.1 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.0 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.0 | 0.2 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.0 | 0.2 | GO:1901663 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.0 | 0.1 | GO:0006311 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.0 | 0.0 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
0.0 | 0.0 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 0.0 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.0 | 0.7 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.0 | GO:0072505 | divalent inorganic anion homeostasis(GO:0072505) |
0.0 | 0.0 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.0 | 0.2 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.0 | 1.8 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.0 | 0.0 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.1 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.1 | GO:0046688 | response to copper ion(GO:0046688) |
0.0 | 0.0 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.0 | 0.0 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.0 | 0.0 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.0 | 3.6 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.0 | 0.1 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.0 | 0.2 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.0 | 0.0 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.0 | 0.0 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.0 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.0 | 0.1 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.3 | 16.0 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
3.6 | 10.7 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
3.0 | 9.0 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
3.0 | 14.9 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
2.7 | 21.9 | GO:0043083 | synaptic cleft(GO:0043083) |
2.7 | 8.1 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
2.3 | 4.7 | GO:0097451 | glial limiting end-foot(GO:0097451) |
2.3 | 6.9 | GO:0097441 | basilar dendrite(GO:0097441) |
2.1 | 10.4 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
1.9 | 17.4 | GO:0030673 | axolemma(GO:0030673) |
1.9 | 9.4 | GO:0097433 | dense body(GO:0097433) |
1.9 | 18.7 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.8 | 7.3 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
1.8 | 5.4 | GO:0097427 | microtubule bundle(GO:0097427) |
1.8 | 1.8 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
1.8 | 10.8 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.8 | 7.2 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
1.7 | 3.4 | GO:1990812 | growth cone filopodium(GO:1990812) |
1.6 | 6.4 | GO:0033010 | paranodal junction(GO:0033010) |
1.6 | 12.4 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
1.5 | 6.1 | GO:0044308 | axonal spine(GO:0044308) |
1.5 | 63.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.5 | 27.2 | GO:0060077 | inhibitory synapse(GO:0060077) |
1.4 | 4.3 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
1.4 | 2.8 | GO:0030478 | actin cap(GO:0030478) |
1.3 | 7.9 | GO:0016012 | sarcoglycan complex(GO:0016012) |
1.3 | 3.9 | GO:0036396 | MIS complex(GO:0036396) |
1.2 | 3.7 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
1.2 | 9.8 | GO:0071437 | invadopodium(GO:0071437) |
1.2 | 7.3 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
1.2 | 2.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.2 | 2.4 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
1.2 | 7.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
1.1 | 3.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.1 | 4.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
1.1 | 13.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.1 | 14.8 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
1.0 | 34.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
1.0 | 1.0 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
1.0 | 2.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
1.0 | 4.1 | GO:0030891 | VCB complex(GO:0030891) |
1.0 | 1.0 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.9 | 3.7 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.9 | 2.7 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.9 | 2.7 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.9 | 21.3 | GO:0044295 | axonal growth cone(GO:0044295) |
0.9 | 3.5 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.9 | 0.9 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.9 | 2.6 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.8 | 2.5 | GO:0071942 | XPC complex(GO:0071942) |
0.8 | 3.3 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.8 | 11.3 | GO:0097440 | apical dendrite(GO:0097440) |
0.8 | 2.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.8 | 6.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.8 | 2.4 | GO:0043511 | inhibin complex(GO:0043511) |
0.8 | 17.2 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.8 | 3.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.8 | 2.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.8 | 3.8 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.7 | 6.6 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.7 | 2.9 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.7 | 24.7 | GO:0043198 | dendritic shaft(GO:0043198) |
0.7 | 4.3 | GO:0071986 | Ragulator complex(GO:0071986) |
0.7 | 7.1 | GO:0043194 | axon initial segment(GO:0043194) |
0.7 | 16.3 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.7 | 3.5 | GO:0044327 | dendritic spine head(GO:0044327) |
0.7 | 1.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.7 | 3.5 | GO:0032584 | growth cone membrane(GO:0032584) |
0.7 | 1.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.7 | 1.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.7 | 3.4 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.7 | 0.7 | GO:0044298 | cell body membrane(GO:0044298) |
0.7 | 2.7 | GO:0070876 | SOSS complex(GO:0070876) |
0.7 | 5.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.6 | 4.5 | GO:0070187 | telosome(GO:0070187) |
0.6 | 1.9 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.6 | 2.5 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.6 | 3.1 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.6 | 4.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.6 | 1.8 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.6 | 2.4 | GO:0070545 | PeBoW complex(GO:0070545) |
0.6 | 8.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.6 | 4.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.6 | 3.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.6 | 1.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.6 | 1.7 | GO:0070552 | BRISC complex(GO:0070552) |
0.6 | 6.7 | GO:0031527 | filopodium membrane(GO:0031527) |
0.6 | 73.9 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.6 | 6.7 | GO:0031045 | dense core granule(GO:0031045) |
0.6 | 2.2 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.5 | 1.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.5 | 3.2 | GO:0044292 | dendrite terminus(GO:0044292) |
0.5 | 14.2 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.5 | 2.6 | GO:0097449 | astrocyte projection(GO:0097449) |
0.5 | 1.6 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.5 | 1.5 | GO:0055087 | Ski complex(GO:0055087) |
0.5 | 3.6 | GO:0000801 | central element(GO:0000801) |
0.5 | 2.0 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.5 | 2.0 | GO:0098536 | deuterosome(GO:0098536) |
0.5 | 5.5 | GO:0042555 | MCM complex(GO:0042555) |
0.5 | 1.5 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.5 | 1.5 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.5 | 7.8 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.5 | 4.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.5 | 6.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.5 | 3.4 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.5 | 2.4 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.5 | 1.4 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.5 | 0.9 | GO:0000802 | transverse filament(GO:0000802) |
0.5 | 1.8 | GO:0033268 | node of Ranvier(GO:0033268) |
0.5 | 26.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.4 | 2.7 | GO:0070852 | cell body fiber(GO:0070852) |
0.4 | 1.3 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.4 | 2.6 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.4 | 3.9 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.4 | 0.4 | GO:1990635 | proximal dendrite(GO:1990635) |
0.4 | 4.3 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.4 | 2.1 | GO:0070820 | tertiary granule(GO:0070820) |
0.4 | 3.0 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.4 | 1.7 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.4 | 3.3 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.4 | 3.3 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.4 | 2.0 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.4 | 1.6 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.4 | 0.4 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.4 | 3.9 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.4 | 1.6 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.4 | 0.4 | GO:0043219 | lateral loop(GO:0043219) |
0.4 | 1.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.4 | 1.5 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.4 | 1.5 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.4 | 2.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.4 | 1.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.4 | 0.4 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.4 | 1.5 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.4 | 0.4 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.4 | 17.4 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.4 | 3.9 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.4 | 0.4 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.3 | 4.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.3 | 4.1 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.3 | 6.8 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.3 | 21.9 | GO:0030426 | growth cone(GO:0030426) |
0.3 | 2.9 | GO:0005869 | dynactin complex(GO:0005869) |
0.3 | 16.6 | GO:0043197 | dendritic spine(GO:0043197) |
0.3 | 1.3 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.3 | 0.3 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.3 | 1.2 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.3 | 2.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.3 | 0.9 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.3 | 1.5 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.3 | 0.3 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.3 | 2.6 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.3 | 0.3 | GO:0005642 | annulate lamellae(GO:0005642) |
0.3 | 1.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.3 | 3.0 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 0.5 | GO:0042585 | germinal vesicle(GO:0042585) |
0.3 | 1.1 | GO:1990130 | Iml1 complex(GO:1990130) |
0.3 | 0.8 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.3 | 1.1 | GO:0000235 | astral microtubule(GO:0000235) |
0.3 | 1.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.3 | 1.0 | GO:1990246 | uniplex complex(GO:1990246) |
0.3 | 1.3 | GO:0000796 | condensin complex(GO:0000796) |
0.3 | 0.3 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.3 | 0.5 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.3 | 0.8 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.2 | 0.2 | GO:0005687 | U4 snRNP(GO:0005687) |
0.2 | 1.9 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.2 | 46.9 | GO:0030424 | axon(GO:0030424) |
0.2 | 2.2 | GO:0000124 | SAGA complex(GO:0000124) |
0.2 | 1.0 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 3.4 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.2 | 0.7 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 1.4 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 7.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 0.9 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 2.9 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.2 | 3.3 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.2 | 0.7 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 0.4 | GO:0032010 | phagolysosome(GO:0032010) |
0.2 | 12.7 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.2 | 0.4 | GO:0072534 | perineuronal net(GO:0072534) |
0.2 | 1.5 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.2 | 1.7 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.2 | 1.2 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.2 | 1.6 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 1.8 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 1.0 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.2 | 1.2 | GO:0002177 | manchette(GO:0002177) |
0.2 | 0.6 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 0.6 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.2 | 3.6 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.2 | 0.8 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.2 | 1.0 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.2 | 1.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 0.8 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.2 | 1.9 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.2 | 7.5 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.2 | 0.7 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.2 | 1.6 | GO:0005686 | U2 snRNP(GO:0005686) |
0.2 | 6.5 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 1.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 0.7 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.2 | 1.3 | GO:0001741 | XY body(GO:0001741) |
0.2 | 0.5 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 2.6 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.2 | 1.5 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.2 | 1.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 0.6 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.2 | 0.8 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 2.9 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.2 | 1.5 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 0.6 | GO:0030897 | HOPS complex(GO:0030897) |
0.2 | 0.2 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.2 | 1.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 0.2 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.2 | 1.4 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 0.9 | GO:0005688 | U6 snRNP(GO:0005688) |
0.1 | 5.1 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.8 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.6 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.9 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 1.4 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.5 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 20.8 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 0.2 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.9 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 1.4 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.6 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 1.9 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 0.3 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.6 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.5 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 1.4 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 1.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 2.9 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.7 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.3 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 0.7 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 3.9 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 1.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.7 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 1.0 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.4 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 0.5 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 0.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.3 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.1 | 0.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 1.0 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.4 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 0.6 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.1 | 7.1 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 19.3 | GO:0036477 | somatodendritic compartment(GO:0036477) |
0.1 | 0.3 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 0.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 5.3 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 0.3 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 3.4 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 3.0 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 1.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 0.1 | GO:0005767 | secondary lysosome(GO:0005767) |
0.1 | 0.1 | GO:0044393 | microspike(GO:0044393) |
0.1 | 0.3 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.1 | 6.6 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.1 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.1 | 0.2 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.1 | 1.0 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 0.1 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 2.4 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.1 | GO:0051286 | cell tip(GO:0051286) |
0.1 | 0.4 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.1 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.1 | 0.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 1.2 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.0 | 0.1 | GO:0031417 | NatC complex(GO:0031417) |
0.0 | 0.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.0 | 0.2 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 0.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.0 | 0.4 | GO:0097060 | synaptic membrane(GO:0097060) |
0.0 | 0.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.1 | GO:0030689 | Noc complex(GO:0030689) |
0.0 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.2 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.0 | 0.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.7 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.5 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.1 | GO:0000805 | X chromosome(GO:0000805) |
0.0 | 0.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 0.1 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 2.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.1 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 0.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.0 | 0.2 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 0.1 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) lumenal side of membrane(GO:0098576) |
0.0 | 0.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.1 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.0 | 0.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 0.0 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.1 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.0 | 0.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.7 | 11.0 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
3.6 | 7.3 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
3.5 | 10.4 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
3.2 | 12.9 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
3.1 | 15.5 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
2.9 | 8.8 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
2.8 | 11.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
2.8 | 11.3 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
2.6 | 7.9 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
2.6 | 18.1 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
2.5 | 7.5 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
2.4 | 12.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
2.3 | 7.0 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
2.3 | 6.9 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
2.3 | 11.5 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
2.3 | 6.8 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
2.1 | 12.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
2.0 | 6.1 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
2.0 | 4.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.9 | 5.8 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.9 | 11.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
1.8 | 7.3 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
1.8 | 5.3 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
1.8 | 7.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
1.7 | 12.2 | GO:0003680 | AT DNA binding(GO:0003680) |
1.7 | 6.8 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.7 | 5.1 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
1.6 | 4.8 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
1.5 | 7.6 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.4 | 15.8 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
1.4 | 2.9 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
1.4 | 1.4 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
1.4 | 5.5 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
1.4 | 4.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
1.3 | 14.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.3 | 6.6 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
1.3 | 2.6 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
1.3 | 5.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
1.3 | 5.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.3 | 6.4 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.3 | 5.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
1.3 | 3.8 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.2 | 3.7 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
1.2 | 3.7 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
1.2 | 3.7 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
1.2 | 6.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
1.2 | 3.7 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
1.2 | 6.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.2 | 3.7 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
1.2 | 5.9 | GO:0070883 | pre-miRNA binding(GO:0070883) |
1.2 | 2.4 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.2 | 3.5 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
1.2 | 6.9 | GO:0048495 | Roundabout binding(GO:0048495) |
1.1 | 6.9 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
1.1 | 4.5 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
1.1 | 4.5 | GO:0000403 | Y-form DNA binding(GO:0000403) |
1.1 | 3.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.1 | 4.3 | GO:0015265 | urea channel activity(GO:0015265) |
1.1 | 3.2 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
1.1 | 3.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
1.1 | 3.2 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
1.1 | 16.9 | GO:0004890 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
1.0 | 4.2 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
1.0 | 2.1 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
1.0 | 3.0 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
1.0 | 10.7 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
1.0 | 4.9 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
1.0 | 1.9 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.9 | 3.8 | GO:0031489 | myosin V binding(GO:0031489) |
0.9 | 18.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.9 | 10.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.9 | 7.5 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.9 | 0.9 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.9 | 4.6 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.9 | 2.7 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.9 | 0.9 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.9 | 2.6 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.9 | 2.6 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.8 | 3.4 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.8 | 2.5 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.8 | 0.8 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.8 | 2.5 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.8 | 0.8 | GO:0009374 | biotin binding(GO:0009374) |
0.8 | 23.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.8 | 8.9 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.8 | 8.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.8 | 7.3 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.8 | 2.4 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.8 | 7.2 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.8 | 0.8 | GO:0003896 | DNA primase activity(GO:0003896) |
0.8 | 1.6 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.8 | 3.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.8 | 2.3 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.8 | 12.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.8 | 2.3 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.7 | 3.7 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.7 | 2.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.7 | 1.4 | GO:0097016 | L27 domain binding(GO:0097016) |
0.7 | 2.8 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.7 | 2.1 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.7 | 9.9 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.6 | 2.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.6 | 3.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.6 | 2.6 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.6 | 1.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.6 | 2.6 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.6 | 1.9 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.6 | 6.3 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.6 | 1.9 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.6 | 3.1 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.6 | 0.6 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.6 | 1.9 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.6 | 1.9 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.6 | 1.8 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.6 | 3.7 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.6 | 1.8 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.6 | 0.6 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.6 | 3.0 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.6 | 1.8 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.6 | 12.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.6 | 6.5 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.6 | 8.2 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.6 | 2.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.6 | 3.5 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.6 | 2.3 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.6 | 2.9 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.6 | 1.7 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.6 | 2.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.6 | 5.7 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.6 | 1.7 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.6 | 4.0 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.6 | 4.5 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.6 | 2.8 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.6 | 6.1 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.6 | 2.8 | GO:0002054 | nucleobase binding(GO:0002054) |
0.5 | 2.7 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.5 | 2.2 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.5 | 2.7 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.5 | 2.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.5 | 6.4 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.5 | 1.6 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.5 | 1.1 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.5 | 1.6 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.5 | 6.3 | GO:0016594 | glycine binding(GO:0016594) |
0.5 | 0.5 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.5 | 0.5 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.5 | 11.5 | GO:0004120 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.5 | 0.5 | GO:0086056 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.5 | 3.6 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.5 | 1.6 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.5 | 14.3 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.5 | 4.1 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.5 | 5.0 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.5 | 2.0 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.5 | 1.5 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.5 | 1.5 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.5 | 1.5 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.5 | 1.5 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.5 | 3.4 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.5 | 1.0 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.5 | 0.5 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.5 | 1.9 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.5 | 2.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.5 | 1.4 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.5 | 7.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.5 | 1.4 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.5 | 1.4 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.5 | 1.4 | GO:0019862 | IgA binding(GO:0019862) |
0.5 | 2.7 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.5 | 0.5 | GO:0016595 | glutamate binding(GO:0016595) |
0.5 | 1.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.5 | 0.9 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.4 | 1.3 | GO:0008495 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.4 | 2.2 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.4 | 6.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.4 | 1.3 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.4 | 1.3 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.4 | 4.4 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.4 | 3.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.4 | 1.8 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.4 | 0.9 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.4 | 8.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.4 | 7.7 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.4 | 4.7 | GO:0048156 | tau protein binding(GO:0048156) |
0.4 | 3.8 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.4 | 1.3 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.4 | 1.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.4 | 1.7 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.4 | 1.7 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.4 | 7.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.4 | 1.2 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.4 | 6.9 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.4 | 1.6 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.4 | 2.4 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.4 | 1.6 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.4 | 4.8 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.4 | 2.0 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.4 | 0.4 | GO:0016428 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.4 | 0.8 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.4 | 0.4 | GO:0008425 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
0.4 | 1.6 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.4 | 1.2 | GO:0089720 | caspase binding(GO:0089720) |
0.4 | 1.6 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.4 | 4.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.4 | 3.9 | GO:0051378 | serotonin binding(GO:0051378) |
0.4 | 7.7 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.4 | 9.6 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.4 | 2.7 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.4 | 1.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.4 | 4.1 | GO:0005522 | profilin binding(GO:0005522) |
0.4 | 2.2 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.4 | 3.3 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.4 | 0.7 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.4 | 3.7 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.4 | 0.4 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.4 | 3.3 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.4 | 1.8 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.4 | 1.8 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.4 | 1.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.4 | 5.0 | GO:0070402 | NADPH binding(GO:0070402) |
0.4 | 0.7 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.4 | 1.4 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.4 | 1.8 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.4 | 0.7 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.4 | 6.7 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.4 | 3.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.3 | 0.7 | GO:0034046 | poly(G) binding(GO:0034046) |
0.3 | 1.7 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.3 | 7.9 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.3 | 1.4 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.3 | 0.7 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.3 | 3.4 | GO:0070628 | proteasome binding(GO:0070628) |
0.3 | 3.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.3 | 2.4 | GO:0030957 | Tat protein binding(GO:0030957) |
0.3 | 3.4 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.3 | 1.3 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.3 | 4.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.3 | 1.3 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.3 | 7.0 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.3 | 2.0 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.3 | 1.6 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.3 | 1.3 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.3 | 1.3 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.3 | 0.3 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.3 | 2.3 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.3 | 0.3 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.3 | 1.6 | GO:1990254 | keratin filament binding(GO:1990254) |
0.3 | 2.2 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.3 | 5.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.3 | 3.5 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.3 | 3.7 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.3 | 0.6 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.3 | 0.6 | GO:0045340 | mercury ion binding(GO:0045340) |
0.3 | 18.2 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.3 | 7.4 | GO:0050699 | WW domain binding(GO:0050699) |
0.3 | 2.1 | GO:0046790 | virion binding(GO:0046790) |
0.3 | 0.3 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.3 | 2.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.3 | 0.9 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.3 | 1.7 | GO:0034711 | inhibin binding(GO:0034711) |
0.3 | 0.9 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.3 | 5.7 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.3 | 5.1 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.3 | 0.8 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.3 | 1.1 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.3 | 0.3 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.3 | 0.8 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.3 | 7.5 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.3 | 0.8 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.3 | 1.1 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.3 | 0.3 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.3 | 1.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.3 | 2.2 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.3 | 6.8 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.3 | 0.5 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.3 | 0.8 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.3 | 1.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.3 | 0.8 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.3 | 0.3 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.3 | 1.6 | GO:0005267 | potassium channel activity(GO:0005267) |
0.3 | 0.8 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.3 | 0.3 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.3 | 1.3 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.3 | 1.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.3 | 0.8 | GO:0050693 | LBD domain binding(GO:0050693) |
0.3 | 0.3 | GO:0030984 | kininogen binding(GO:0030984) |
0.3 | 0.5 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.3 | 0.5 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.3 | 3.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.3 | 6.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.3 | 1.3 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.3 | 1.3 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.3 | 0.5 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.3 | 1.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.3 | 1.0 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.3 | 0.8 | GO:0015232 | heme transporter activity(GO:0015232) |
0.2 | 1.5 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 6.0 | GO:0019894 | kinesin binding(GO:0019894) |
0.2 | 2.0 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.2 | 1.0 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.2 | 0.7 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 2.6 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.2 | 0.5 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.2 | 1.4 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 1.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 1.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 1.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.2 | 0.9 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.2 | 0.7 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 0.7 | GO:0043199 | sulfate binding(GO:0043199) |
0.2 | 8.4 | GO:0043022 | ribosome binding(GO:0043022) |
0.2 | 5.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 0.9 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 2.9 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.2 | 1.1 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
0.2 | 16.5 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.2 | 2.2 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.2 | 0.4 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.2 | 0.9 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 1.3 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.2 | 3.2 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.2 | 1.1 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 1.3 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.2 | 1.1 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 0.9 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 0.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 1.0 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 0.4 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.2 | 0.4 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.2 | 0.4 | GO:0097001 | ceramide binding(GO:0097001) |
0.2 | 1.0 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.2 | 0.4 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.2 | 1.2 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.2 | 1.4 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.2 | 1.0 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.2 | 0.8 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.2 | 0.2 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.2 | 8.1 | GO:0043621 | protein self-association(GO:0043621) |
0.2 | 0.8 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.2 | 0.4 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.2 | 0.4 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.2 | 1.0 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 0.2 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.2 | 0.6 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 1.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 2.8 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.2 | 0.6 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 3.2 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 2.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 0.2 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.2 | 2.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 0.6 | GO:0004103 | choline kinase activity(GO:0004103) |
0.2 | 2.8 | GO:0008483 | transaminase activity(GO:0008483) |
0.2 | 0.4 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.2 | 0.4 | GO:0070840 | dynein complex binding(GO:0070840) |
0.2 | 3.7 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 0.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.2 | 0.7 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.2 | 1.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.2 | 1.4 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.2 | 1.2 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 0.5 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.2 | 2.4 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.2 | 0.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 3.1 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.2 | 0.2 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.2 | 0.2 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.2 | 1.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 1.5 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 0.3 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.2 | 1.0 | GO:0004952 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) |
0.2 | 5.5 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.2 | 0.7 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 0.7 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.2 | 0.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 3.6 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.2 | 0.5 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.2 | 0.3 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.2 | 1.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.2 | 1.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 0.9 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.2 | 0.5 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 1.1 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.2 | 1.7 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.2 | 0.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 4.8 | GO:0016876 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 1.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.7 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.4 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.7 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 3.8 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.1 | GO:0016405 | CoA-ligase activity(GO:0016405) |
0.1 | 1.0 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 5.4 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 0.1 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 1.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.1 | 0.4 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.3 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 1.1 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.6 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
0.1 | 0.7 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.7 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.6 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.8 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 1.6 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 1.5 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.8 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 1.1 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 1.2 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 1.1 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.1 | 0.5 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.6 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.1 | 1.0 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.1 | 0.1 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.1 | 1.0 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.4 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.5 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 2.2 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.7 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) |
0.1 | 0.2 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 2.0 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.1 | 0.2 | GO:0001032 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.1 | 0.6 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 1.5 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.1 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.1 | 6.9 | GO:1902936 | phosphatidylinositol bisphosphate binding(GO:1902936) |
0.1 | 0.1 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.1 | 1.9 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 3.5 | GO:0043765 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.1 | 0.7 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 1.9 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.9 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 1.1 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.2 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 0.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 1.0 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.2 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.1 | 2.7 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.7 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 3.0 | GO:0019905 | syntaxin binding(GO:0019905) |
0.1 | 1.5 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 11.7 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 0.4 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.1 | 0.8 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 0.5 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 1.6 | GO:0009975 | cyclase activity(GO:0009975) |
0.1 | 0.1 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.1 | 0.4 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.1 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.1 | 0.1 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.1 | 0.4 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 1.0 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.1 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 0.7 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.2 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 0.1 | GO:0018595 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.1 | 0.4 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.9 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 0.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.2 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 0.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.2 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.6 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 0.5 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 0.7 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.3 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.1 | 0.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.7 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 1.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.8 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.2 | GO:0018574 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.1 | 3.2 | GO:0015631 | tubulin binding(GO:0015631) |
0.1 | 0.1 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.1 | 0.2 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.1 | 0.1 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.1 | 0.3 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.1 | 0.2 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.3 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 1.7 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.1 | 0.3 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.1 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.1 | 0.3 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 9.5 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.7 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.3 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.4 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.3 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 0.5 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 0.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 7.1 | GO:0003729 | mRNA binding(GO:0003729) |
0.1 | 0.4 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 0.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.1 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.1 | 0.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.6 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.1 | 0.2 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.1 | 0.7 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.2 | GO:0005272 | sodium channel activity(GO:0005272) |
0.1 | 0.2 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 0.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.8 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.1 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.1 | 0.2 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 1.4 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 2.1 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.0 | 0.0 | GO:0015927 | trehalase activity(GO:0015927) |
0.0 | 0.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.0 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.2 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 2.1 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.3 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 1.2 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.2 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.0 | 0.7 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.6 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.1 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 0.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.3 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.1 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.0 | 15.4 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.2 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.3 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 1.1 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 9.3 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.1 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.0 | 0.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.1 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.0 | 0.7 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.0 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.0 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.0 | 0.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.0 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.0 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.2 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.0 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 0.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.2 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.0 | 0.1 | GO:0004031 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.0 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.7 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 1.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.8 | 24.9 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.6 | 8.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.6 | 0.6 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.6 | 5.7 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.6 | 7.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.6 | 11.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.5 | 6.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.5 | 9.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.5 | 11.4 | PID REELIN PATHWAY | Reelin signaling pathway |
0.4 | 0.4 | ST GAQ PATHWAY | G alpha q Pathway |
0.4 | 3.8 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.4 | 0.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.4 | 16.4 | PID SHP2 PATHWAY | SHP2 signaling |
0.4 | 12.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.4 | 5.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.4 | 4.7 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.4 | 5.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.3 | 0.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.3 | 3.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.3 | 2.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.3 | 3.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.2 | 1.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 0.5 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 8.8 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.2 | 0.6 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 3.3 | ST ADRENERGIC | Adrenergic Pathway |
0.2 | 2.8 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 3.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.2 | 0.7 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.2 | 6.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 2.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 3.7 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 2.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 1.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 1.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 0.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 1.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 2.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 1.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 0.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 0.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 2.9 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 1.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.2 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 0.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 1.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 2.7 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 0.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 2.8 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 0.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 0.9 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.5 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 1.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.3 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 41.0 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
2.3 | 32.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
1.8 | 19.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.6 | 18.9 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.5 | 16.6 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
1.5 | 25.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.4 | 4.1 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
1.2 | 17.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.2 | 2.3 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
1.0 | 18.4 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.8 | 13.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.8 | 33.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.7 | 16.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.7 | 11.6 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.7 | 3.6 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.7 | 13.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.7 | 0.7 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.7 | 2.8 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.7 | 1.4 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.7 | 0.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.7 | 19.1 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.6 | 6.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.6 | 8.9 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.6 | 8.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.6 | 10.7 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.6 | 8.7 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.6 | 9.5 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.6 | 4.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.6 | 5.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.6 | 10.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.6 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.6 | 1.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.5 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.5 | 7.0 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.5 | 12.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.5 | 2.2 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.5 | 3.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.5 | 4.0 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.5 | 1.0 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.5 | 6.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.5 | 4.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.4 | 3.5 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.4 | 2.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.4 | 4.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.4 | 4.7 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.4 | 5.1 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.4 | 3.8 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.4 | 1.3 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.4 | 5.0 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.4 | 5.8 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.4 | 7.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.4 | 6.0 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.4 | 1.2 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.4 | 3.5 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.4 | 5.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.4 | 1.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.4 | 10.3 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.4 | 2.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.4 | 4.1 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.4 | 4.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.4 | 7.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.4 | 1.4 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.4 | 1.1 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.3 | 6.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 13.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.3 | 4.8 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.3 | 2.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.3 | 4.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.3 | 5.2 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.3 | 6.0 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.3 | 5.3 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.3 | 2.8 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.3 | 8.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.3 | 4.3 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.3 | 0.6 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.3 | 6.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.3 | 5.3 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.3 | 0.8 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.3 | 0.8 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.3 | 3.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.3 | 4.2 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.3 | 10.9 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.3 | 2.0 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.2 | 1.0 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.2 | 10.4 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.2 | 4.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.2 | 2.4 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.2 | 0.2 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.2 | 0.7 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.2 | 2.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 4.1 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.2 | 2.0 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 0.6 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.2 | 2.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 2.7 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.2 | 2.8 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.2 | 2.2 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.2 | 2.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 3.5 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.2 | 3.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 5.1 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.2 | 0.8 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.2 | 3.4 | REACTOME KINESINS | Genes involved in Kinesins |
0.2 | 2.1 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 2.2 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 7.1 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.1 | 0.4 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.1 | 1.0 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 0.9 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 2.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 0.1 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.1 | 1.2 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.1 | 0.6 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 0.2 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 0.8 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.1 | 0.9 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 1.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 1.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 2.6 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 0.7 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 0.4 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.1 | 2.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 0.2 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 0.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 2.1 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 0.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.1 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 2.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 1.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 0.6 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 1.1 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 1.3 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 1.0 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 0.4 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 5.6 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 0.8 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 3.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.2 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 0.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 0.7 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.6 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 0.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 1.1 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.1 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 2.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.6 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.6 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.0 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.2 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.5 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.6 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.3 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.3 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.0 | 1.3 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.9 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.0 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.0 | 0.0 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.5 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.0 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |